PARD3/Par3 Antibody (833517) [DyLight 550]
Novus Biologicals, part of Bio-Techne | Catalog # FAB8030L
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry
Label
DyLight 550 (Excitation = 562 nm, Emission = 576 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # 833517
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human PARD3/Par3
Tyr451-Glu555
Accession # Q8TEW0
Tyr451-Glu555
Accession # Q8TEW0
Specificity
Detects human PARD3/Par3 in ELISAs.
In direct ELISAs, 100% cross-reactivity with recombinant human PARD3b/Par3b is observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for PARD3/Par3 Antibody (833517) [DyLight 550]
Application
Recommended Usage
Immunocytochemistry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PARD3/Par3
Long Name
Par-3 Partitioning Defective 3 Homolog
Alternate Names
ASIP, Baz, Bazooka, PAR3, PAR3A, SE2-5L16, SE2-5LT1, SE2-5T2
Gene Symbol
PARD3
Additional PARD3/Par3 Products
Product Documents for PARD3/Par3 Antibody (833517) [DyLight 550]
Product Specific Notices for PARD3/Par3 Antibody (833517) [DyLight 550]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...